WesselsBW, KonijnenbergMW, DaleRGet al.MIRD Pamphlet No. 20: The effect of model assumptions on kidney dosimetry and response—implications for radionuclide therapy. J Nucl Med, 2008; 49:1884.
2.
EmamiB, LymanJ, BrownAet al.Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys, 1991; 21:109.
CremonesiM, FerrariM, BodeiLet al.Dosimetry in peptide radionuclide receptor therapy: A review. J Nucl Med, 2006; 47:1467.
5.
BouchetLG, BolchWE, BlancoHPet al.MIRD Pamphlet No 19: Absorbed fractions and radionuclide S values for six age-dependent multiregion models of the kidney. J Nucl Med, 2003; 44:1113.
6.
GearaFB, PetersLJ, AngKKet al.Prospective comparison of in vitro normal cell radiosensitivity and normal tissue reactions in radiotherapy patients. Int J Radiat Oncol Biol Phys, 1993; 27:1173.
7.
HallEJ. Radiobiology for the Radiologist, 2nd. Philadelphia: Harper & Row, 1978.
8.
FowlerJF. 21 years of biologically effective dose. Br J Radiol, 2010; 83:554.
9.
BrennerDJ, HlatkyLR, HahnfeldtPJet al.The linear-quadratic model and most other common radiobiological models result in similar predictions of time–dose relationships. Radiat Res, 1998; 150:83.
10.
ThamesHD, HendryJH. Fractionation in Radiotherapy. London: Taylor & Francis, 1987.
